Farallon Capital Management LLC Cara Therapeutics, Inc. Transaction History

Farallon Capital Management LLC

  • $20.7 Billion
  • Q2 2024

A detailed history of Farallon Capital Management LLC transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Farallon Capital Management LLC holds 1,556,251 shares of CARA stock, worth $466,875. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,556,251
Holding current value
$466,875
% of portfolio
0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$0.6 - $1.65 $933,750 - $2.57 Million
1,556,251 New
1,556,251 $1.15 Million
Q3 2023

Nov 14, 2023
BUY
$1.67 - $3.33 $2.78 Million - $5.55 Million
1,666,591 New
1,666,591 $2.8 Million
Q2 2023

Aug 14, 2023
SELL
$2.83 - $4.94 $930,444 - $1.62 Million
-328,779 Reduced 16.48%
1,666,591 $4.72 Million
Q1 2023

May 15, 2023
SELL
$4.89 - $12.27 $385,478 - $967,244
-78,830 Reduced 3.8%
1,995,370 $9.8 Million
Q4 2022

Feb 14, 2023
SELL
$8.88 - $12.77 $3.78 Million - $5.44 Million
-425,800 Reduced 17.03%
2,074,200 $22.3 Million
Q1 2022

May 16, 2022
BUY
$9.94 - $12.65 $4.97 Million - $6.33 Million
500,000 Added 25.0%
2,500,000 $30.4 Million
Q2 2021

Aug 13, 2021
SELL
$12.38 - $29.19 $5.76 Million - $13.6 Million
-465,000 Reduced 18.86%
2,000,000 $28.5 Million
Q4 2020

Feb 16, 2021
BUY
$12.72 - $16.16 $2.73 Million - $3.47 Million
215,000 Added 9.56%
2,465,000 $37.3 Million
Q3 2020

Nov 16, 2020
SELL
$12.34 - $17.92 $617,000 - $896,000
-50,000 Reduced 2.17%
2,250,000 $28.6 Million
Q4 2019

Feb 13, 2020
BUY
$16.11 - $25.98 $2.42 Million - $3.9 Million
150,000 Added 6.98%
2,300,000 $37.1 Million
Q3 2019

Nov 14, 2019
BUY
$18.28 - $26.91 $21.9 Million - $32.3 Million
1,198,674 Added 126.0%
2,150,000 $39.3 Million
Q2 2019

Aug 14, 2019
BUY
$17.68 - $21.57 $16.8 Million - $20.5 Million
951,326 New
951,326 $20.5 Million

Others Institutions Holding CARA

# of Institutions
84
Shares Held
16.4M
Call Options Held
55K
Put Options Held
500
View Full List

About Cara Therapeutics, Inc.

CARA Quotes by TradingView
  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $16.1M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Farallon Capital Management LLC Portfolio

Follow Farallon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email